| CM (n = 1419) | Without MOH (n = 620) | With MOH (n = 799) | p value |
---|---|---|---|---|
Age | 41.7 ± 13.9 | 40.6 ± 14.6 | 42.5 ± 13.2 | 0.008 |
Female gender | 80.0% | 79.8% | 80.1% | 0.903 |
Age at migraine onset (years) | 21.8 ± 10.7 | 23.1 ± 11.3 | 20.8 ± 10.0 | < 0.001 |
Duration of CM (months) | 78.6 ± 107.1 | 59.7 ± 99.5 | 92.9 ± 110.4 | < 0.001 |
Age at CM onset (years) | 35.6 ± 14.0 | 36.0 ± 14.7 | 35.3 ± 13.4 | 0.370 |
Time from migraine onset to CM onset (years) | 14.1 ± 11.7 | 13.1 ± 11.8 | 14.9 ± 11.5 | 0.007 |
Average headache severity (/10) | 6.7 ± 2.0 | 6.1 ± 1.9 | 7.1 ± 1.9 | < 0.001 |
Monthly headache days | 23.3 ± 6.6 | 23.0 ± 6.7 | 23.6 ± 6.5 | 0.069 |
Monthly analgesic use (days/month) | 12.8 ± 10.4 | 4.0 ± 5.5 | 19.7 ± 7.8 | < 0.001 |
Hypnotic use ≥ 3 days/week | 32.0% | 21.0% | 40.5% | < 0.001 |
Tobacco use | 13.6% | 9.1% | 17.2% | < 0.001 |
Alcohol use | 32.0% | 33.7% | 30.6% | 0.220 |
Caffeine use | 65.1% | 64.2% | 65.1% | 0.519 |
HIT-6 | 63.8 ± 7.7 | 62.5 ± 7.0 | 64.8 ± 8.1 | < 0.001 |
HADS-A | 9.4 ± 4.5 | 9.3 ± 4.5 | 9.5 ± 4.6 | 0.385 |
HADS-D | 7.8 ± 4.5 | 7.4 ± 4.4 | 8.1 ± 4.6 | 0.002 |
PSQI | 11.5 ± 4.3 | 11.0 ± 4.1 | 12.0 ± 4.3 | < 0.001 |
LDQ | 8.9 ± 8.1 | 3.9 ± 5.0 | 12.8 ± 7.8 | < 0.001 |
SDS | 4.9 ± 4.1 | 2.3 ± 2.8 | 6.9 ± 3.9 | < 0.001 |